Background and Objective Buffy coat (BC) pooling sets are integrated systems, consisting of a pooling bag, a filter and a platelet storage container, for the production of leucoreduced platelet concentrates (LR-PCs) from pooled BCs. It was our aim to compare various pooling sets that are currently marketed.
Introduction
Platelet concentrates (PCs), recovered from buffy coats (BCs) may be pooled and leucoreduced prior to storage [1] . Various components, such as a pooling bag, a filter and a storage container, are connected with a sterile connection device to obtain a sterile, closed system. Such a composite system allows the users to choose products (from different manufacturers, if necessary) that suit their requirements. A drawback of this method is that the necessary welding is rather expensive, while there is always a theoretical risk that these connections may introduce bacterial contamination.
Various manufacturers now produce closed, fully integrated BC pooling sets that consist of a pooling bag, a filter and a storage container. These sets have a tubing system for connection of multiple BCs and a unit plasma or additive solution. Furthermore, some sets have a sample pouch attached to the storage container for quality control, and a needle or sample port to allow sampling for bacterial culture.
Our aim was to compare filters and storage containers currently marketed as BC pooling sets. The study was divided into two parts: one to evaluate the characteristics of the various leucoreduction filters in the sets, in respect to platelet yield and leucocyte removal; and the other to compare the pH, blood gases, glucose, lactate, lactate dehydrogenase (LDH) release and swirl, of platelets stored in various bags from these sets.
Materials and methods

Whole blood collection and BC preparation
Whole blood (mean 470 ml, range 405-495 ml) was collected in triple top-and-bottom bag systems with 63 ml of citratephosphate-dextrose (CPD) as anticoagulant (Fresenius Hemocare, Emmer-Compascuum, the Netherlands). One satellite bag contained 100 ml of saline-adenine-glucose-mannitol (SAGM) as additive solution for the red cells. The units were cooled within 2 h to 20 -24 ° C by placing them under butane-1, 4-diol plates, and were subsequently stored under these plates at room temperature overnight. The following day, the units were centrifuged at 2960 g in a Beckman J6MI centrifuge (28 000 g/ min) (Beckman, Palo Alto, CA) [2] . The units were divided into plasma, a red cell concentrate and a BC using a Compomat G4 (Fresenius). This device has two presses that can be extended horizontally, expressing plasma to the upper and red cells to the lower satellite bag of the bottom and top system. The Compomat was programmed to yield a BC of 50 ml with a haematocrit of 40% [3] .
Study I: comparison of filters applied in BC pooling sets
Five ABO-identical BC were welded to a 450-ml pooling bag (P4213; Fresenius) with six leads, using a sterile connection device (SCD-201 A; Terumo, Tokyo, Japan). To the sixth lead, a unit of PAS-II (Baxter, Maurepas, France) was welded. After the contents of the BC bags had been transferred to the pooling bag, the pooling bag was placed on a scale and 250 g of PAS-II was added.
The contents of four of these ABO-identical BC pools were pooled into a 2000-ml transfer bag (BB*2000BB; Terumo) and again divided between the original BC pooling bags, to prevent differences induced by donor variation. One of the following filters was welded to each of the bags from one paired set: Autostop (art. no. ATSBC1; Pall Medsep, Torquay, UK), BioP-plus (art. no. A2CE0460; Fresenius Hemocare), Imugard III S-PL (art. no. TF*FP1AB2DB; Terumo, Tokyo, Japan) or CLX-5 (art. no. PLX-5CB1-H; Sepacell; distributed by Baxter, Utrecht, the Netherlands). The Imugard filter is made of polyurethane and has a soft housing, the other filters are made of polyester and have a hard filter housing.
For expression of the platelet-rich supernatant (PRS), the centrifuged BC pool bag was hung on suspension pins in the Compomat G4 [3] . After closing the door of the Compomat, the upper and lower presses were automatically extended horizontally, expressing the PRS to a collection bag. Reduction of flow speed prevented whirling of the interface layer. The expression was automatically terminated when the red cell layer activated a detector that was positioned upstream just before the filter, giving the highest platelet yield. The tubing was then automatically sealed, and the set could be removed from the Compomat. The soft housing of the Imugard filter was allowed to collapse to remove any PRS left in the filter. In total, 12 such experiments were performed.
Study II: comparison of storage containers used in BC pooling sets PRS was produced as described above, with the exception that the BC pools were not pooled and divided prior to centrifugation. After centrifugation and expression of PRS on the Compomat, the PC was leucoreduced using the BioP-05 'polishing' filter (B4000; Fresenius Hemocare), as described in detail previously [4] . Five of these (ABO-identical) leucoreduced PCs (LR-PCs) were pooled into a 2000-ml bag, and then divided equally between the following storage containers: 1000-ml and 1500-ml containers made of polyolefin (polypropylene Kraton G and ethylene ethylacrilate copolymer) (art. nos P4110 and P4100, respectively; Fresenius); 1500-ml containers made from CLX-plastic (tri-2-(ethylhexyl)trimellitaat) (art. no. ATSBC1; Pall Medsep), 1300-ml PL2410 (butyryl trihexyl citrate plasticized PVC) (art. no. R7004; Baxter) and 1000-ml PVC containers with di-n -decyl phthalate (DnDP) as plasticizer (art. no. BB* T100BM; Terumo).
The units were weighed, the swirling score was determined on a scale from 0 to 3 according to Fratantoni et al. [5] and, using a sample site coupler, a 3-ml sample was taken aseptically from each of the bags for in vitro measurements. The bags were placed on a flat-bed shaker (Melco, Glendale, CA), which was adjusted to 60 strokes per minute, and kept in a climate-controlled cabinet (Forma Scientific, Breukelen, the Netherlands) for 9 days. Sampling was repeated on days 2, 5, 7 and 9. Ten storage experiments were performed.
In vitro measurements
The volume of the units was calculated from the net weight divided by the specific gravity (1·016 g/ml for a mixture of 65% PAS-II and 35% plasma). Cell counts and measurement of the mean platelet volume (MPV) were performed on a CA570 cell analyser (Medonic, Bromma, Sweden). Leucocytes were counted in the Nageotte haemocytometer using a sample diluted 1 : 5 in the lysing and counting solution, Leucoplate (Labo International, Maarssen, the Netherlands), and the whole grid was counted (50 µ l). When no cells were observed, the residual number of leucocytes was taken to be < 0·03 × 10 6 per unit of 300 ml. Red cells were counted in a Bürker haemocytometer using a sample diluted 1 : 5 in phosphate-buffered saline. The whole grid (0·9 µ l) was counted. Absolute numbers of cells were calculated from cell counts and the volume. pH, P CO 2 , P O 2 and bicarbonate were measured on an AVL 945 blood gas analyser at 37 ° C (AVL Medical Instruments, Graz, Austria). The lower level of accurate measurement of pH with this analyser is 6·5. Glucose, lactate and LDH levels were measured on a Beckman CX-7 analyser, using standard kits.
Requirements for PCs
The following parameters were set for the leucoreduced platelets in additive solution [6] : a volume of 150-400 ml; a platelet number of > 240 × 10 9 , resulting in a platelet concentration of 0·8-1·5 × 10 9 /ml; a leucocyte number of < 1 × 10 6 ; a red cell number of < 5 × 10 9 ; a pH of 6·8-7·4 throughout the storage period; and presence of the swirling effect until the end of the storage period.
Statistics
The repeated-measures analysis of variance ( ANOVA ) (Instat version 2·04; GraphPad Software, San Diego, CA) was used to determine differences among the various filters, among the various storage containers and to compare the storage parameters during storage with the day-1 value. Post-tests were performed using the Tukey-Kramer test to calculate differences for filters and storage containers, while Dunnetts multiple comparisons test was used to compare storage parameters with the value on day 1. A P -value of < 0·05 was considered to indicate a statistically significant difference.
Results
Study I: comparison of filters
As shown in Table 1 , the composition of the pooled and subsequently divided BC pools was not significantly different for most of the parameters analysed, although minor but significant differences were observed for the volume (Autostop vs. BioP-plus and Imugard: P < 0·01; CLX vs. Imugard: P < 0·05) and number of leucocytes (Autostop vs. Imugard: P < 0·05).
The leucocyte removal was not significantly different for the investigated filters, and the number of residual leucocytes was, in all cases, well below the level of 1 × 10 6 per LR-PC.
The number of platelets in the LR-PCs was significantly lower following filtration with the BioP-plus filter as compared to 
Residue Volume, ml 144 ± 9 143 ± 6 139 ± 7 142 ± 9 Haematocrit, % 60 ± 2 60 ± 1 6 1 ± 1 60 ± 3 Platelets, × 10 9 96 ± 19 85 ± 12 74 ± 14 75 ± 21 Leucocytes, × 10 9 10·3 ± 1·0 10·5 ± 0·9 9·1 ± 2·2 8·1 ± 2·0 a P < 0·001, BioP-plus vs. the other filters. Data were obtained from 12 experiments and results are expressed as mean ± SD. LR-PCs, leucoreduced platelet concentrates.
Table 1
Composition of buffy coat (BC) pools that were pooled and divided to prevent donor-dependent differences, and composition of the platelet concentrates (PCs) subsequently produced (which were leucocyte reduced using four different filters) and the residues of the BC pools after expression of platelet-rich plasma (PRS) the others ( P < 0·001), with 10 of 12 containing < 240 × 10 9 platelets per unit. Platelet numbers using the other filters all conformed to our requirements. As the residues of the BC pools after expression of the PRS from all four tested filters contained equal numbers of platelets, we presume that many platelets are lost in the large filter housing of the BioP-plus filter. The red cell contamination of the LR-PCs was not significantly different among the four filters, and was well below our requirements.
Study II: comparison of storage containers
The composition of the LR-PCs stored in five different containers showed no significant difference on day 1 for any of the cellular parameters, and are therefore reported as pooled data (mean ± SD; n = 50): a volume of 285 ± 12 ml (range 261-310 ml), containing 295 ± 18 × 10 9 platelets (range 261-332 × 10 9 platelets), resulting in a platelet concentration of 1·04 ± 0·07 × 10 6 /ml (0·94-1·20 × 10 9 /ml). The mean leucocyte content was 0·06 ± 0·04 × 10 6 per unit and the red cell contamination was 0·36 ± 0·26 × 10 9 .
Comparison between storage days
During storage, as shown in Fig. 1 , all PCs showed a significant change in pH (comparison with day 1: P < 0·01, except for 1500-ml polyolefin and DnDP-PVC bags: day 1 vs. days 2 and 5: NS). Bicarbonate levels showed significant changes from day 5 onwards (P < 0·01), but had already reached significance on day 2 for the 1000-ml polyolefin and CLX bags (P < 0·05). O 2 and CO 2 levels were significantly different on day 2 (P < 0·01), with the exception of the O 2 levels of the 1500-ml polyolefin container (days 2, 5 and 7: NS), and the CO 2 levels in the 1500-ml polyolefin bag (days 2 and 5: NS) and the DnDP-PVC bag (all days NS). Glucose levels were significantly lower from day 5 onwards (P < 0·01) for all containers, and lactate was significantly higher from day 2 onwards for the polyolefin containers (P < 0·01) and from day 5 for the other containers (P < 0·01). Finally, LDH release was significantly higher from day 5 onwards (P < 0·01). Surprisingly, LDH values for the CLX bag become significant only on day 9 as compared to the day-1 values.
Comparison between storage containers
As shown in Fig. 1 , storage of the LR-PCs revealed that the pH remained > 6·8 until day 9 for all containers except the CLX bag (P < 0·001). This container showed a rapid fall in pH, with pH < 6·8 in two of nine cases on day 5, and the swirling scores decreased accordingly (see Fig. 1 ). In the CLX bag, the metabolism appeared to be very high, reflected by high glucose consumption and subsequent high lactate production. The O 2 levels, however, were not significantly different for all five containers until day 5, while from day 7 onwards the PO 2 was significantly higher in the CLX container as compared to the other containers (P < 0·001), which implies adequate oxygenation. Therefore, anaerobic metabolism cannot explain the rapid pH fall. The PCO 2 and the bicarbonate levels dropped steadily during the storage period in the CLX bag. The average MPV was not significantly different for the storage containers, with a mean value of 8·7 ± 0·4 fl throughout the storage period, except for the CLX bag which showed a rise in MPV to 9·9 ± 0·6 fl on day 9 (P < 0·001), suggesting platelet swelling and/or activation.
Experience of handling of various filters and containers
The benefits of a fully integrated system for production of PCs has been outlined previously, but other features of the systems are important for their use in a blood centre. The flexible housing of the Imugard filter allowed us to pack the filter in the centrifuge cup together with the bags, and the Autostop filter was stacked on top of the pooling bag. The BioP-plus and the CLX filter had large filter housings and had to be placed next to the pooling bag. This caused problems: the outlet of the BioP-plus filter broke once during centrifugation, and once the CLX-5 filter perforated the pooling bag. Additionally, a weld leaked between the BC pooling bag and the filter on one occasion during expression of PRS on the Compomat G4.
Discussion
Evaluation of the filters present in various BC pooling sets revealed that these filters are able to reduce the number of residual leucocytes to well below 1 × 10 6 for LR-PCs in additive solution. The BioP-plus filter showed a low platelet recovery, which can be explained by the large housing of the filter. In this filter, the final part of the PRS (with a volume of ≈ 30 ml) is captured, which contains a high concentration of platelets originating from just above the red cell interface. Therefore, this filter is less suitable for leucoreduction of PCs under these conditions. Storage of the LR-PCs in additive solution in five different containers revealed that most containers were able to maintain a pH of > 6·8 until day 9, and these results are in accordance with those reported by others [7, 8] . However, LR-PCs stored in the CLX container showed a rapid decrease in pH, with two of nine experiments not conforming to our requirements on day 5 of storage, which is the currently accepted storage period for platelets.
A low pH of stored LR-PCs is associated with high metabolism and/or inadequate oxygenation [8] . The latter can be excluded as, from day 5 onwards, O 2 levels were higher and CO 2 levels were lower compared to the other bags, indicating 
Day
Swirl 1300-ml PL2410 (Baxter) 1000-ml PO (Fresenius) 1500-ml PO (Fresenius) 1500-ml CLX (Pall) 1000-ml DnDP-PVC (Terumo) Fig. 1 Representation of various parameters of leucoreduced platelet concentrates (LR-PCs) in PAS-II additive solution (n = 10 experiments), stored for 9 days in the following storage containers: 1000-ml and 1500-ml polyolefin (Fresenius); 1000-ml di-n-decyl phthalate (DnDP)-PVC (Terumo); 1300-ml PL2410 (Baxter); and 1500-ml CLX (Pall). The vertical lines represent standard deviation (SD) bars. LDH, lactate dehydrogenase. that the gas exchange of the container was adequate. We therefore theorize that the platelets are stimulated by the CLX foil, probably owing to the rough grid pattern on the inside of the container (visual observation). The platelets experience a continuous shear stress that may induce activation: glucose levels decreased, lactate quickly rose after day 5 and bicarbonate was quickly depleted. Cell injury occurred after day 5, reflected by the high LDH levels and no swirl, and the increasing O 2 and decreasing CO 2 levels suggest that metabolism had ceased [8] .
In this study, some problems were observed, which may be important when a pooling set is selected for large-scale routine use. Of special concern are the filters that broke during centrifugation or perforated the bags. By developing sophisticated methods or using special inserts for packing the bags and filters in the centrifuge cup the breakage may be prevented, and this mandates training of the staff.
Another problem was a weld that leaked during expression on the Compomat. With the careful expression of PRS with the flow reducer set at 5%, a pressure of ≈ 0·2-0·3 bar can build up. Visual inspection of the welds for integrity (by opening the weld and manually squeezing against a light source), was apparently not sufficient under these experimental conditions. In our view, this reflects the need for fully integrated BC pooling sets for production of PCs, if expressed on an automated separator.
Finally, it should be noted that for the storage study, only one filter was used for leucoreduction, to prevent differences induced by the filter. However, only an evaluation of the complete set (i.e. a specific combination of a pooling bag, a filter and a storage container) under routine blood banking conditions will reveal whether the selected set is suitable for large-scale application.
We conclude that the development of fully integrated sets for pooling, filtration and storage of PCs, in combination with expression of the PRS on an automated separator, can result in a reliable and user-friendly production method for the production of LR-PCs. However, validation is mandatory prior to implementation in routine use.
